Sorafenib
- 18 January 2019
- book chapter
- book charpter
- Published by Elsevier BV
- Vol. 44, 239-266
- https://doi.org/10.1016/bs.podrm.2018.11.003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Nano Determination of KinaseInhibitor Sorafenib Drug in Pharmaceutical Formulation and Human Blood at a Modified Carbon Paste ElectrodeJournal of the Electrochemical Society, 2016
- Determination of the Anticancer Drug Sorafenib in Serum by Adsorptive Stripping Differential Pulse Voltammetry Using a Chitosan/Multiwall Carbon Nanotube Modified Glassy Carbon ElectrodeElectroanalysis, 2015
- DEVELOPMENT AND VALIDATION OF A RAPID AND SIMPLE HPLC-UV METHOD FOR THE ANALYSIS OF SORAFENIB IN THE PRESENCE OF POLYAMIDOAMINE (PAMAM) DENDRIMERSJournal of Liquid Chromatography & Related Technologies, 2014
- A Quantitative HPLC-UV Method for Determination of Serum Sorafenib and Sorafenib N-Oxide and Its Application in Hepatocarcinoma PatientsThe Tohoku Journal of Experimental Medicine, 2014
- Quantitative Estimation of Sorafenib Tosylate Its Pure Form and in Its Tablet Formulation by RP-HPLC MethodJournal of Chemistry, 2013
- Convenient Synthesis of Sorafenib and Its DerivativesSynthetic Communications, 2011
- High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluidCancer Chemotherapy and Pharmacology, 2010
- Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practiceJournal of Pharmaceutical and Biomedical Analysis, 2009
- Validation of a liquid chromatography assay for the quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serumJournal of Chromatography B, 2004
- A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of CancerOrganic Process Research & Development, 2002